Chemie Und Biochemie Des Xanthins

Allen M. J. , Boyland E. , Dukes C. E. , Horning E. S. , Watson J. G. : Brit. J. Cancer., 11; 212–228 (1957).

Berry H. K. , Granger M. : Uric acid excretion in infants and children. Clin. Chim. Acta, 32; 377–383 (1971).

Boyle J. A. , Seegmiller J. E. : Selected aspects of the etiology, pathogenesis and treatment of disorders of purine metabolism. In: Modern Trend in Rheumatology, Hill A.G.S. , Ed., 2: 299–322, Butterworth, London 1972.

Brill J. M. , McCarty D. J. : Arthr. & Rheum., 8; 267–288 (1965).

Bywaters E. G. L. , Holloway V. P. : Measurement of serum uric acid in Great Britain in 1963. Ann. rheum. Dis., 23; 236–239 (1964).

Carawal W. T. , Marable H. : Comparison of carbonate and uricase carbonate methods for the determination of uric acid in serum. Clin. Chem., 12; 18–24 (1966).

Cotton R. G. H. , Camakaris J. , Danks D. M. : A screening test for urinary purines and pyrimidines and related compounds using anxotrophic mutants of E. Coli K-12. Biochem. Med., 3; 326–336 (1970).

Dent C. E. , Philpot G. R. : Xanthinuria, an inborn error (or deviation) of metabolism. Lancet, 1; 182 (1954).

Dickinson C. J. , Smellie J. M. : Xanthinuria. Brit. med. J., 2; 1217 (1959).

Engleman K. , Watts R. W. E. , Klinenberg J. R. , Sjoerdsma A. , Seegmiller J. E. : Clinical, physical and biochemical studies of a patient with xanthinuria and pheochromocytoma. Amer. J. Med., 37; 839 (1964).

Freudweiler M. : Experimentelle Untersuchungen über die Entstehung der Gichtknoten. Dtsch. Arch. klin. Med., 69; 155–205 (1901).

Goldfinger : J. clin. Invest., 44; 623 (1965).

Gots J. S. : Regulation of purine and pyrimidine metabolism. In: Metabolic Pathways, 3rd ed., Vol. 5, Metabolic Regulation, pp. 225–255, Vogel H. J. Ed., Academic Press, New York 1971.

Greene M. J. , Fujimoto W. Y. , Seegmiller J. E. : Fed. Proc., 27; 1057 (1968).

Hartung E. F. : Historical considerations. Metabolism, 6; 196–208 (1957).

Jones C. E. , Smith E. E. , Hicks W. , Crowell J. W. : Determination of urinary purines in hyperuricosuric children by thinlayer chromatography. J. Lab. clin. Med., 76; 163–170 (1970).

Kelley W. N. , Greene M. L. , Rosenbloom F. M. , Henderson J. F. , Seegmiller J. E. : Hypoxanthine-guanine phosphoribosyl-transferase deficiency in gout: A review. Ann. intern. Med., 70; 155–206 (1969).

Kit S. : Nucleotides and nucleic acids. Metab. Pathways, 4; 70–275 (1970).

Klinenberg J. R. , Goldfinger S. , Miller J. , Seegmiller J. E. : The effectiveness of a xanthin oxidase inhibitors on the treatment of gout. Ann. intern. Med., 62; 639 (1965).

Klinenberg J. R. , Goldfinger S. , Miller J. , Seegmiller J. E. : The effectiveness of a xanthine oxidase inhibitor in the treatment of gout. Arthr. Rheum., 6; 779 (1963).

Krakoff : Med. Clin. N. Amer., 45; 521 (1961).

Kuhl : Metabolism, 4; 143 (1955).

Mikkelsen : J. Lab. clin. Med., 60; 999 (1962).

Mertz D. P. : Gicht, Grundlagen. Klinik und Therapie, 2. Aufl., S. 444, G. Thieme, Stuttgart 1973.

Rundles R. W. , Wyngaarden J. B. , Hitchings G. H. , Elion G. B. , Silberman H. R. : Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout. Trans. Ass. Amer. Phys., 76; 126 (1963).

Rundles R. W. , Wyngaarden J. B. , Hitchings G. H. , Elion G. B. : Drugs and uric acid. Ann. Rev. Pharmacol., 9; 345 (1969).

Sweetman L. : Urinary and cerebrospinal fluid oxypurine levels and allopurinol metabolism in Lesch-Nyhan syndroms. Fed. Proc., 27; 1055 (1968).

Talbott J. H. : Gout, 3rd ed., Grune & Stratton, New York 1967.

Woeber K. A. , Ricca L. , Hills A. G. : Pathogenesis of uric acid urolithiasis. Clin. Res., 10; 45 (1962).

Yü T. F. , Gutman A. B. : Effect of allopurinol on scrum and urinary uric acid in primary and secondary gout. Amer. J. Med., 37; 885 (1964).